Associate Director Therapeutics, Deep Science Ventures
Kerstin started her PhD at German Cancer Research Centre and then moved to a lab at Imperial College to work on novel treatment options within the field of tumour immunology. She has since spent almost ten years in leadership roles at impact-driven organisations advancing medicine and therapeutics, while also securing an executive MBA and a women in business award. Before joining Deep Science Ventures to design novel therapeutics companies using DSV’s outcome focussed company creation process, Kerstin was transforming ideas for cutting edge cell and gene therapies into investable propositions at UK’s Cell and Gene Therapy Catapult.
Stevenage Bioscience Catalyst30 November 2023